L3-5103B monoclonal antibody prod uction phase III
Ended Awarded
- Contract number
- HHSN272NYI48180
- Awardee
-
Lofstrand Labs LTD UEI RLR6V78VM2F1
- Awarding agency
-
NIAID DEA OA Acquisitions
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,559
Award facts
- Contract value
-
- $2,558.54 Current, with exercised options
- $0.00 Potential, with all options
- Completion date
-
- Current, with exercised options
- Not on record Potential, with all options
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- 0 offers Simplified Acquisition
- Pricing
- Other
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN272NYI48180?
HHSN272NYI48180 was awarded to Lofstrand Labs LTD by NIAID DEA OA Acquisitions (National Institutes of Health) on November 27, 2006.
How much is contract HHSN272NYI48180 worth?
The government has obligated $2,559 on HHSN272NYI48180.
Which agency awarded contract HHSN272NYI48180?
NIAID DEA OA Acquisitions (National Institutes of Health) awarded HHSN272NYI48180, with funding from Office of the Director (National Institutes of Health).
Is contract HHSN272NYI48180 an order under another contract?
Yes. HHSN272NYI48180 is a BPA call under HHSN263200000053507B, a blanket purchase agreement.
Was contract HHSN272NYI48180 competed?
The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award